Viewing Study NCT00598793


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-04-12 @ 5:36 AM
Study NCT ID: NCT00598793
Status: COMPLETED
Last Update Posted: 2017-01-09
First Post: 2008-01-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module